Stock listing
NASDAQ:VIGL Vigil Neuroscience Inc Stock
Follow Vigil Neuroscience Inc into a list and get an email when it puts out news.
Last close · NASDAQ:VIGL
$8.05 USD
Close on Aug 5, 2025 · No longer trades
- Lowest – highest close
- $1.40 – $17.29 USDSince Jan 7, 2022 · lowest Apr 8, 2025 · highest Feb 16, 2022
Delisted NASDAQ:VIGL no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:VIGL
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Vigil Neuroscience Inc on 6ix
- Decks
- 6 decks · latest Jan 11, 2024
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| JP Morgan Healthcare Conference 2024 | Conference | 31 slides | Jan 11, 2024 |
| Technical Presentation (November 2023) | Technical | 56 slides | Nov 16, 2023 |
| Technical Presentation (September 2023) | Technical | 71 slides | Sep 13, 2023 |
| JP Morgan Healthcare Conference 2023 | Conference | 29 slides | Jan 9, 2023 |
| Technical Presentation (December 2022) | Technical | 127 slides | Dec 6, 2022 |
| Technical Presentation (November 2022) | Technical | 20 slides | Nov 2, 2022 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Suzanne L. Bruhn Other companies: Definium Therapeutics, Inc. (Board Member · Since at least Aug 11, 2022); Pliant Therapeutics, Inc. (Director · Since at least Jun 2, 2020); Travere Therapeutics, Inc. (Director · Since at least Apr 8, 2020); Avalo Therapeutics, Inc. (Director · Apr 24, 2020 – Nov 10, 2021 · Past); Novelion Therapeutics Inc (Director · Oct 1, 2017 – Aug 9, 2018 · Past); Spyre Therapeutics, Inc. (Director · Feb 15, 2017 – Jun 8, 2020 · Past); Raptor Pharmaceutical Corp (Director · Sep 25, 2012 – Oct 24, 2016 · Past) | Director · Since at least Jul 27, 2022 |
| Cheryl R. Blanchard Other companies: Xilio Therapeutics, Inc. (Board Member · Since at least Apr 15, 2026); Anika Therapeutics Inc. (Director · Since at least Aug 31, 2018); Dare Bioscience, Inc. (Director · Nov 20, 2019 – Jun 21, 2023 · Past); Neuronetics, Inc. (Director · Feb 13, 2019 – May 26, 2020 · Past); SeaSpine Holdings Corp (Director · Jul 1, 2015 – May 30, 2018 · Past); Zimmer Biomet Holdings, Inc. (Sr. VP, Chief Scientific Off. · Feb 17, 2011 – Mar 19, 2012 · Past) | Director · Since at least Jan 6, 2022 |
| Mary Thistle Other companies: Aktis Oncology, Inc. (Independent Director · Since at least Jan 8, 2026); Cullinan Therapeutics, Inc. (Chair of the Compensation Committee · Since at least Aug 8, 2024); Entrada Therapeutics, Inc. (Industry Leader and Independent Director · Since at least Oct 28, 2021); Q32 Bio Inc. (Director · Since at least Mar 27, 2018); Alaunos Therapeutics, Inc. (Director · Nov 15, 2020 – Jun 6, 2023 · Past); Dimension Therapeutics (Chief Operating Officer · Feb 1, 2017 – Nov 7, 2017 · Past) | Director · Since at least Apr 18, 2022 |
| Bruce Booth Other companies: Sionna Therapeutics, Inc. (Director · Since at least Feb 6, 2025); Kymera Therapeutics, Inc. (Co-Founder · Since at least Mar 12, 2021); Tectonic Therapeutic, Inc. (Director · Jun 10, 2021 – Jun 6, 2023 · Past); Dianthus Therapeutics, Inc. (Director · Jun 1, 2021 – Jun 28, 2022 · Past) | Director · Since at least Jan 6, 2022 |
| Ivana Magovčević-Liebisch Other companies: Quanterix Corporation (President · Since at least Oct 2, 2024); Acrivon Therapeutics, Inc. (Director · Since at least Feb 8, 2024); Absci Corporation (Director · Jul 21, 2021 – Jun 8, 2022 · Past); Spyre Therapeutics, Inc. (Director · Jun 8, 2021 – Jun 22, 2023 · Past) | President and CEO, Director · Since at least Jan 6, 2022 |
| Spyros Papapetropoulos Other companies: Neuphoria Therapeutics Inc. (Interim CEO & Executive Director · Since at least Jul 1, 2024); Lipocine Inc. (Director · Since at least Apr 11, 2022); Adamas Pharmaceuticals Inc (Director · Nov 22, 2020 – Nov 24, 2021 · Past) | Chief Medical Officer · Jan 6, 2022 – Nov 18, 2022 · Past |
| Stefan Vitorovic Other companies: Tectonic Therapeutic, Inc. (Director · Since at least Jun 20, 2024); Praxis Precision Medicines, Inc. (Director · May 26, 2022 – May 26, 2022 · Past) | Director · Since at least Jun 9, 2022 |
| Jennifer Lynn Ziolkowski Other companies: Solid Biosciences Inc. (CFO, Treasurer & Asst. Secy · Jan 25, 2018 – Jan 27, 2021 · Past) | Chief Financial Officer, Director · Since at least Jan 6, 2022 |
| Christopher Silber | Chief Medical Officer · Aug 7, 2023 – Aug 7, 2023 · Past |
| Christopher Verni | General Counsel · Apr 19, 2022 – May 3, 2024 · Past |
Log in to ask 6ix AI your own questions about Vigil Neuroscience Inc.